SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001088875-23-000101
Filing Date
2023-08-01
Accepted
2023-08-01 08:56:01
Documents
1

Document Format Files

Seq Description Document Type Size
1 ChinookTherapeutics31122020.txt SC 13G/A 9230
  Complete submission text file 0001088875-23-000101.txt   10901
Mailing Address CALTON SQUARE 1 GREENSIDE ROW EDINBURGH X0 EH13AN
Business Address CALTON SQUARE 1 GREENSIDE ROW EDINBURGH X0 EH13AN 00441312752000
BAILLIE GIFFORD & CO (Filed by) CIK: 0001088875 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0
Type: SC 13G/A

Mailing Address 400 FAIRVIEW AVENUE NORTH, SUITE 900 SEATTLE WA 98109
Business Address 400 FAIRVIEW AVENUE NORTH, SUITE 900 SEATTLE WA 98109 206-485-7051
CHINOOK THERAPEUTICS, INC. (Subject) CIK: 0001435049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88812 | Film No.: 231129804
SIC: 2834 Pharmaceutical Preparations